These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19805307)

  • 1. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide.
    Nguyen QD; Smith G; Glaser M; Perumal M; Arstad E; Aboagye EO
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16375-80. PubMed ID: 19805307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal and spatial evolution of therapy-induced tumor apoptosis detected by caspase-3-selective molecular imaging.
    Nguyen QD; Lavdas I; Gubbins J; Smith G; Fortt R; Carroll LS; Graham MA; Aboagye EO
    Clin Cancer Res; 2013 Jul; 19(14):3914-24. PubMed ID: 23729364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging caspase-3 activation as a marker of apoptosis-targeted treatment response in cancer.
    Chen DL; Engle JT; Griffin EA; Miller JP; Chu W; Zhou D; Mach RH
    Mol Imaging Biol; 2015 Jun; 17(3):384-93. PubMed ID: 25344147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomography.
    Witney TH; Fortt R; Aboagye EO
    PLoS One; 2014; 9(3):e91694. PubMed ID: 24618809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98.
    Zhou D; Chu W; Chen DL; Wang Q; Reichert DE; Rothfuss J; D'Avignon A; Welch MJ; Mach RH
    Org Biomol Chem; 2009 Apr; 7(7):1337-48. PubMed ID: 19300818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy.
    Elvas F; Vanden Berghe T; Adriaenssens Y; Vandenabeele P; Augustyns K; Staelens S; Stroobants S; Van der Veken P; Wyffels L
    Org Biomol Chem; 2019 May; 17(19):4801-4824. PubMed ID: 31033991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical translation of [
    Dubash SR; Merchant S; Heinzmann K; Mauri F; Lavdas I; Inglese M; Kozlowski K; Rama N; Masrour N; Steel JF; Thornton A; Lim AK; Lewanski C; Cleator S; Coombes RC; Kenny L; Aboagye EO
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2285-2299. PubMed ID: 30259091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis.
    Qiu L; Wang W; Li K; Peng Y; Lv G; Liu Q; Gao F; Seimbille Y; Xie M; Lin J
    Theranostics; 2019; 9(23):6962-6975. PubMed ID: 31660080
    [No Abstract]   [Full Text] [Related]  

  • 9. Imaging apoptosis with positron emission tomography: 'bench to bedside' development of the caspase-3/7 specific radiotracer [(18)F]ICMT-11.
    Nguyen QD; Challapalli A; Smith G; Fortt R; Aboagye EO
    Eur J Cancer; 2012 Mar; 48(4):432-40. PubMed ID: 22226480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Kinetic Analysis of the Caspase-3/7 PET Tracer 18F-C-SNAT: Quantifying the Changes in Blood Flow and Tumor Retention After Chemotherapy.
    Palner M; Shen B; Jeon J; Lin J; Chin FT; Rao J
    J Nucl Med; 2015 Sep; 56(9):1415-21. PubMed ID: 26045308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis.
    Zhou D; Chu W; Rothfuss J; Zeng C; Xu J; Jones L; Welch MJ; Mach RH
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5041-6. PubMed ID: 16891117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent.
    Faust A; Wagner S; Law MP; Hermann S; Schnöckel U; Keul P; Schober O; Schäfers M; Levkau B; Kopka K
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):67-73. PubMed ID: 17372575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of new fluorinated, 2-substituted 5-pyrrolidinylsulfonyl isatin derivatives as caspase-3 and caspase-7 inhibitors: nonradioactive counterparts of putative PET-compatible apoptosis imaging agents.
    Limpachayaporn P; Schäfers M; Schober O; Kopka K; Haufe G
    Bioorg Med Chem; 2013 Apr; 21(7):2025-36. PubMed ID: 23411396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isatin sulfonamides: potent caspases-3 and -7 inhibitors, and promising PET and SPECT radiotracers for apoptosis imaging.
    Limpachayaporn P; Schäfers M; Haufe G
    Future Med Chem; 2015; 7(9):1173-96. PubMed ID: 26132525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved radiosynthesis of the apoptosis marker 18F-ICMT11 including biological evaluation.
    Glaser M; Goggi J; Smith G; Morrison M; Luthra SK; Robins E; Aboagye EO
    Bioorg Med Chem Lett; 2011 Dec; 21(23):6945-9. PubMed ID: 22030029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumors.
    Xia CF; Chen G; Gangadharmath U; Gomez LF; Liang Q; Mu F; Mocharla VP; Su H; Szardenings AK; Walsh JC; Zhao T; Kolb HC
    Mol Imaging Biol; 2013 Dec; 15(6):748-57. PubMed ID: 23689985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, 18F-radiolabeling, and in vivo biodistribution studies of N-fluorohydroxybutyl isatin sulfonamides using positron emission tomography.
    Limpachayaporn P; Wagner S; Kopka K; Hermann S; Schäfers M; Haufe G
    J Med Chem; 2013 Jun; 56(11):4509-20. PubMed ID: 23656488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography.
    Chen DL; Zhou D; Chu W; Herrbrich PE; Jones LA; Rothfuss JM; Engle JT; Geraci M; Welch MJ; Mach RH
    Nucl Med Biol; 2009 Aug; 36(6):651-8. PubMed ID: 19647171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET.
    Song S; Xiong C; Lu W; Ku G; Huang G; Li C
    J Nucl Med; 2013 Jan; 54(1):104-10. PubMed ID: 23283564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorinated isatin derivatives. Part 3. New side-chain fluoro-functionalized pyrrolidinyl sulfonyl isatins as potent caspase-3 and -7 inhibitors.
    Podichetty AK; Wagner S; Faust A; Schäfers M; Schober O; Kopka K; Haufe G
    Future Med Chem; 2009 Aug; 1(5):969-89. PubMed ID: 21426092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.